company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7297125.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7297125.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,667419.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,564215.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-130270.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6195761.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6195761.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4293.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4293.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4293.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1499276.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-77490.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1576766.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1576766.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7776820.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,247501.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6271942.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6271942.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,655318.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,530135.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5950769.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11037258.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11037258.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5489.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5489.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5489.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-703884.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,248.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-703636.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-703636.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11746383.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,202522.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14684000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14684000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,625000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6590000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-378000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7847000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7847000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1069000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56458000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,55389000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,55389000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47521000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 17:11:30+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,162000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14587000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14587000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,597000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1922000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7367000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19435000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19435000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11604000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11659000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11659000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1105000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,131720000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4327000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,134942000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,134942000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,103848000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,120000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4417000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4417000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,589000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2812000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4161000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5177000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5177000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-378000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-128127000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6488000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-122017000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-122017000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2786000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-70000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2856000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2856000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-130050000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,84000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17886000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17886000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,585000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3244000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-406000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14463000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14463000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-372000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16314000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22554000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5868000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5868000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-36000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-36000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8631000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14098000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14098000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,588000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,414000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3760000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4102000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13438000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13438000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25354000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21273000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4267000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4267000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,118183000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,118146000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,118146000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,100441000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 06:01:00+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25104000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25104000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,562000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,496000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4261000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,978000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18807000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18807000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-651000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-107249000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31806000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-76094000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-76094000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,218000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,218000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94683000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,543000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,315000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4662000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4726000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17036000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17036000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-319000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48696000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48378000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48378000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,359000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,359000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,359000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,31701000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27269000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27269000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,542000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,382000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6757000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11595000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7993000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7993000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3508000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-115202000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5525000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-113185000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-113185000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,117596000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,807000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,118501000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,118403000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-350000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3125000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37915000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37915000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,634000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,486000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9789000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9419000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36425000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36425000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-883000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19108000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40598000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20607000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20607000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3019000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3019000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3019000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-124000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:08:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12923000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29819000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29819000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-294000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25880000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42870000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16696000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16696000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5053000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5053000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5053000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,465000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7605000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27761000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27761000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-587000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89311000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83614000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6284000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6284000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4650000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,150000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,617000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,145967000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,145967000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-430000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,111492000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50948000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50948000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,797000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1231000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9234000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9354000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30332000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30332000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-956000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89463000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38589000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51830000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51830000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,4650000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4628000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-639000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,89000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-82690000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,111000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41233000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41233000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,849000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,703000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10314000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12220000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41587000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41587000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-265000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19413000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41795000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22117000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22117000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,1579000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17857000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 08:26:42+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,225000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38914000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38914000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,815000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,584000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11288000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1642000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24585000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24585000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26843000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47850000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,660000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-1579000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4507000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,39000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35167000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35167000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,813000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,547000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10940000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1208000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24075000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24075000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-265000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27436000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65937000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38236000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38236000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,892000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,892000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,892000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-425000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14628000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2250000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,369000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26796000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26796000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,813000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,353000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9687000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2624000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13319000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13319000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1236000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11685000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36052000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23131000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23131000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1819000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8035000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,310000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29057000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29057000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,612000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,288000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11449000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12194000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28902000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28902000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-225000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19467000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44110000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24418000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24418000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,557000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,106000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,663000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,663000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-394000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4215000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2250000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:48:31+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17475000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17475000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,836000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,262000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10437000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19260000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13320000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13320000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-354000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-76424000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100247000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23469000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23469000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-432000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,40000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,429000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,39997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,39997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2119000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78905000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,224000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,306000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33738000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33738000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10295000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,251000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6839000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,584000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15769000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15769000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-77642000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,76424000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20490000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19272000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19272000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,805000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,902000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1707000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1707000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3617000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8827000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3022000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,282000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1270000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1270000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5939000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,167000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8135000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5777000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,21288000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,21288000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,75120000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-77163000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61901000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9902000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-54042000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-54042000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1106000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,745000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1851000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1851000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,857000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30046000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,775000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,485000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6022000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,30000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8228000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10895000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15878000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15878000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-479000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22683000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21514000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1648000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1648000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1136000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1136000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1136000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2273000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14117000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3023000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 17:13:44+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,326000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9519000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9519000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6221000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-4000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10483000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7178000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-708000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5973000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14425000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7744000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7744000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,119173000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2456000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,121629000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,121629000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3263000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,126113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,815000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,432000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50969000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50969000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7073000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10653000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,36610000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3377000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3377000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5205000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-48892000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29984000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5039000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5080000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5080000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,990000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14666000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3089000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,161000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48330000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48330000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6771000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,55000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11349000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15012000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15143000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15143000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-705000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8433000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39958000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24500000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24596000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24596000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1489000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2237000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3726000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3726000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3611000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39624000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,846000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,664000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72113000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7059000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-118000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12110000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10653000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42409000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42409000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2865000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-165723000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18090000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150498000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150498000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,224441000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1281000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,225722000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,225722000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32815000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3111000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 16:41:46+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,537000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41789000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41789000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7701000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-509000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12112000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8037000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30522000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30522000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13967000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60538000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40334000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38171000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38171000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1667000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1668000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2848000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2849000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2849000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-375000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66219000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,476000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8143000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-313000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10705000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,25960000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15502000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15502000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12522000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13125000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56076000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30429000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30429000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,279571000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,99717000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8066000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,382354000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,382354000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,375000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,397656000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3931000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,918000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-77677000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-77677000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9277000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3421000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5733000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,49040000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10206000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10206000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,15597000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-31682000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-254682000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41770000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-228997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-228997000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5000000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-304000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1507000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6081000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2284000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2284000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1303000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-238222000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,651000.0
PTC Therapeutics Inc,PTCT,549300UJLWOIWFDGB318,0001070081,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,178000.0
